Upgrade to SI Premium - Free Trial

Rani Therapeutics (RANI)

0.91 +0.02 (2.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Rani Therapeutics Holdin For: Jul 21 Filed by: IMRAN MIR A July 23, 2026 4:10 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: Mar 27 Filed by: Javadi Alireza July 21, 2026 7:24 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: Jul 17 Filed by: Imran Talat July 21, 2026 6:29 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: Dec 27 Filed by: Imran Talat July 21, 2026 6:25 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: Jul 17 Filed by: Maestas Nicholas July 21, 2026 4:51 PM - SEC Filing Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 20, 2026 4:05 PM - Globe NewsWire Form S-8 Rani Therapeutics Holdin July 15, 2026 5:10 PM - SEC Filing Rani Therapeutics oral obesity drug tops subcutaneous exposure in Phase 1a July 15, 2026 8:00 AM - StreetInsider Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing July 15, 2026 8:00 AM - Globe NewsWire Rani Therapeutics and PegBio enter obesity drug collaboration July 9, 2026 4:06 PM - StreetInsider Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates July 9, 2026 4:05 PM - Globe NewsWire Form 3 Rani Therapeutics Holdin For: Jun 29 Filed by: Maestas Nicholas July 8, 2026 4:05 PM - SEC Filing Form 8-K Rani Therapeutics Holdin For: Jun 24 June 30, 2026 6:02 AM - SEC Filing Rani Therapeutics names Nicholas Maestas as CFO June 29, 2026 8:02 AM - StreetInsider Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer June 29, 2026 8:00 AM - Globe NewsWire Form 4 Rani Therapeutics Holdin For: Jun 03 Filed by: McKinley Kate June 5, 2026 6:20 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: Jun 03 Filed by: Javadi Alireza June 5, 2026 6:18 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: Jun 03 Filed by: Imran Talat June 5, 2026 6:15 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: May 28 Filed by: Bassan Abraham June 1, 2026 4:11 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: May 28 Filed by: Rometty Lisa Ann June 1, 2026 4:11 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: May 28 Filed by: IMRAN MIR A June 1, 2026 4:10 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: May 28 Filed by: BUTEL JEAN LUC June 1, 2026 4:09 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: May 28 Filed by: Bailey Vasudev Jaiprakash June 1, 2026 4:09 PM - SEC Filing Form 4 Rani Therapeutics Holdin For: May 28 Filed by: Ausiello Dennis A June 1, 2026 4:09 PM - SEC Filing Form 8-K Rani Therapeutics Holdin For: May 28 May 29, 2026 6:03 AM - SEC Filing Form SCHEDULE 13D/A Rani Therapeutics Holdin Filed by: Samsara BioCapital, L.P. May 28, 2026 5:53 PM - SEC Filing Form 8-K Rani Therapeutics Holdin For: May 26 May 27, 2026 6:03 AM - SEC Filing Form 424B5 Rani Therapeutics Holdin May 27, 2026 6:03 AM - SEC Filing Rani Therapeutics prices $20 million stock offering at $1.07 per share May 26, 2026 8:01 AM - StreetInsider Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules May 26, 2026 8:00 AM - Globe NewsWire Canaccord Reiterates Buy Rating on Rani Therapeutics (RANI) May 20, 2026 6:26 AM - StreetInsider Form 10-Q Rani Therapeutics Holdin For: Mar 31 May 15, 2026 4:16 PM - SEC Filing Form 8-K Rani Therapeutics Holdin For: May 11 May 15, 2026 4:13 PM - SEC Filing NASDAQ:RANI reports Q1 2026 results, announces CFO departure May 15, 2026 4:05 PM - StreetInsider Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition May 15, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13G/A Rani Therapeutics Holdin Filed by: SymBiosis Capital Partners, LLC May 15, 2026 11:32 AM - SEC Filing Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference May 12, 2026 4:05 PM - Globe NewsWire Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 12:58 PM - SEC Filing Full Article List